246 related articles for article (PubMed ID: 10824634)
1. Human cardiac beta1- or beta2-adrenergic receptor stimulation and the negative chronotropic effect of low-dose pirenzepine.
Jakubetz J; Schmuck S; Wochatz G; Ruhland B; Poller U; Radke J; Brodde OE
Clin Pharmacol Ther; 2000 May; 67(5):549-57. PubMed ID: 10824634
[TBL] [Abstract][Full Text] [Related]
2. Effects of atropine on human cardiac beta 1- and/or beta 2-adrenoceptor stimulation.
Bruck H; Ulrich A; Gerlach S; Radke J; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):572-7. PubMed ID: 12759717
[TBL] [Abstract][Full Text] [Related]
3. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
[TBL] [Abstract][Full Text] [Related]
4. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
[TBL] [Abstract][Full Text] [Related]
5. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
6. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
Schiffelers SL; Blaak EE; Saris WH; van Baak MA
Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
[TBL] [Abstract][Full Text] [Related]
7. Temporal dynamics of inotropic, chronotropic, and metabolic responses during beta1- and beta2-AR stimulation in the isolated, perfused rat heart.
McConville P; Spencer RG; Lakatta EG
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E412-8. PubMed ID: 15840637
[TBL] [Abstract][Full Text] [Related]
8. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies.
Brodde OE; Konschak U; Becker K; Rüter F; Poller U; Jakubetz J; Radke J; Zerkowski HR
J Clin Invest; 1998 Jan; 101(2):471-8. PubMed ID: 9435320
[TBL] [Abstract][Full Text] [Related]
9. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
[TBL] [Abstract][Full Text] [Related]
10. Neuronally induced augmentation of cardiac output.
Stevenson RS; Thompson GW; Wilkinson M; Murphy DA; Armour JA
Can J Cardiol; 1999 Dec; 15(12):1361-6. PubMed ID: 10620742
[TBL] [Abstract][Full Text] [Related]
11. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic effects of salbutamol, a beta2-selective agonist.
Insulander P; Juhlin-Dannfelt A; Freyschuss U; Vallin H
J Cardiovasc Electrophysiol; 2004 Mar; 15(3):316-22. PubMed ID: 15030423
[TBL] [Abstract][Full Text] [Related]
13. Chronic beta-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart.
Dostanic S; Servant N; Wang C; Chalifour LE
Can J Physiol Pharmacol; 2004 Mar; 82(3):167-74. PubMed ID: 15052282
[TBL] [Abstract][Full Text] [Related]
14. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
15. Differences in the bioenergetic response of the isolated perfused rat heart to selective beta1- and beta2-adrenergic receptor stimulation.
McConville P; Fishbein KW; Lakatta EG; Spencer RG
Circulation; 2003 Apr; 107(16):2146-52. PubMed ID: 12707247
[TBL] [Abstract][Full Text] [Related]
16. Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation.
Bruck H; Leineweber K; Beilfuss A; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2003 Sep; 74(3):255-63. PubMed ID: 12966369
[TBL] [Abstract][Full Text] [Related]
17. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
Khamssi M; Brodde OE
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
[TBL] [Abstract][Full Text] [Related]
18. The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo.
Bruck H; Leineweber K; Büscher R; Ulrich A; Radke J; Insel PA; Brodde OE
Pharmacogenetics; 2003 Feb; 13(2):59-66. PubMed ID: 12563174
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure.
Zhang ZS; Cheng HJ; Ukai T; Tachibana H; Cheng CP
J Pharmacol Exp Ther; 2001 Jul; 298(1):188-96. PubMed ID: 11408541
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in sensitivity to beta-adrenergic agonist isoproterenol in the isolated adult rat heart following prenatal protein restriction.
Elmes MJ; Haase A; Gardner DS; Langley-Evans SC
Br J Nutr; 2009 Mar; 101(5):725-34. PubMed ID: 18590591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
